Ready or not, genomics is coming to hospitals
This year, at a faster pace than many industry insiders anticipated, we're seeing genomics enter the world of real-life care for patients. It took researchers 13 years and about $3 billion to complete the Human Genome Project. A decade later, companies like Illumina (NASDAQ: ILMN) and Life Technologies (NASDAQ: LIFE) are in a fierce competition to sequence genomes at industrial scale, for as little as $1,000 apiece in a single day. But this year we are seeing an increasing wave of demand emerging from hospitals, clinics, and leading physicians who want to take advantage of the new fast and cheap sequencing tools to see if they can be used to help patients.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- Readmissions: No Quick Fix to Costly Hospital Challenge
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- 4 Tips for Managing Employed Physicians
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- House Calls Key to Pioneer ACO Success